spiro[1-azabicyclo[2.2.2]octane-3,2′-oxirane] | CAS:41353-91-7

We serve spiro[1-azabicyclo[2.2.2]octane-3,2′-oxirane] CAS:41353-91-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane]

Chemical Name:spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane]
CAS.NO:41353-91-7
Synonyms:spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane]
3-methylenequiniclidine epoxide
3-methylenequinuclidine epoxide
Spiro-1-azabicyclo[2.2.2]octan-3-oxirane
spiro[1-aza-bicyclo[2.2.2]octane-3,2'-oxirane]
3-methylenequinuclidine oxide
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 211.3±13.0 °C at 760 mmHg
Molecular Formula C8H13NO
Molecular Weight 139.195
Flash Point 60.4±22.2 °C
Vapour Pressure 0.2±0.4 mmHg at 25°C
Index of Refraction 1.564
 
Specification:
Appearance:Yellow to brown liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Cevimeline(CAS:107233-08-9) and Cevimeline hydrochloride(CAS:153504-70-2).



Contact us for information like spiro[1-azabicyclo[2.2.2]octane-3,2′-oxirane] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-methylenequinuclidine oxide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,spiro[1-azabicyclo[2.2.2]octane-3,2′-oxirane] Use and application,3-methylenequinuclidine epoxide technical grade,usp/ep/jp grade.


Related News: The mode of cooperation between domestic API companies and large international companies can lower the export threshold.perfluorooctanoic acid manufacturer The mode of cooperation between domestic API companies and large international companies can lower the export threshold.Ethyl Cyclopropanecarboxylate supplier This followed a declaration Thursday by the World Health Organization that the coronavirus outbreak is a Public Health Emergency of International Concern.1-Chloro-8-fluorooctane vendor In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”